Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Janmohamed ArifDirector |  NAVNNavan, Inc.Grant or award | A | — 9,959 sh | Jun 29, 2026 |
| 5 | Wilkins Joseph D Jr.Director |  QDELQuidelOrtho CorpGrant or award | A | — 15.5K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 5 | Goodrich KatherineDirector |  TARSTarsus Pharmaceuticals, Inc.Grant or award | A | — 2,417 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 4 | Camblong JurgiDirector, Chief Executive Officer |  SOPHSOPHiA GENETICS SAOption exercise · 10b5-1 plan | M | — 31.9K sh | Jun 29, 2026 traded Jun 26, 2026 |
| 4 | Dhanasekaran SatishDirector, President and CEO |  KEYSKeysight Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $183K 507 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 4 | Kumaraswami RaviPres. Worldwide Field Ops. |  RSKDRISKIFIED LTD.Open-market sale · 10b5-1 plan | SELL | $167K 33.4K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 3 | Lin XichenCHIEF SCIENTIFIC OFFICER |  GPCRStructure Therapeutics Inc.Option exercise · 10b5-1 plan | M | $8,036 23.6K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 3 | Lechleider RobertChief Medical Officer |  IMNMImmunome Inc.Option exercise · 10b5-1 plan | M | — 55.0K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 3 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Option exercise · 10b5-1 plan | M | — 23.6K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 3 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Derivative conversion · 10b5-1 plan | C | — 23.6K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 2 | Abrahamsen Danielle NicoleChief Accounting Officer |  CVLTCOMMVAULT SYSTEMS INCGrant or award | A | — 244 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 1 | Kumaraswami RaviPres. Worldwide Field Ops. | RSKDRISKIFIED LTD. Open-market sale · 10b5-1 plan | SELL | $500 100 sh | Jun 29, 2026 traded Jun 26, 2026 |
| 1 | Rosenberg NickExecutive Vice President |  MCBMetropolitan Bank Holding Corp.Open-market sale · 10b5-1 plan | SELL | $9,005 90 sh | Jun 29, 2026 traded Jun 29, 2026 |
| 1 | Rosenberg NickExecutive Vice President | MCBMetropolitan Bank Holding Corp. Open-market sale · 10b5-1 plan | SELL | $26K 263 sh | Jun 29, 2026 traded Jun 26, 2026 |
| 0 | D'Amico AndrewDirector |  VICRVICOR CORPOption exercise · 10b5-1 plan | M | — 200 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 0 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Option exercise · 10b5-1 plan | M | $101K 31.9K sh | Jun 29, 2026 traded Jun 26, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Derivative conversion · 10b5-1 plan | C | — 7,878 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 0 | D'Amico AndrewDirector | VICRVICOR CORP Option exercise · 10b5-1 plan | M | $20K 331 sh | Jun 29, 2026 traded Jun 26, 2026 |
| 0 | D'Amico AndrewDirector | VICRVICOR CORP Option exercise · 10b5-1 plan | M | $20K 200 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 0 | Schmidt James FDirector, CFO, Treasurer, Secretary | VICRVICOR CORP Option exercise · 10b5-1 plan | M | — 1,000 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 0 | Schmidt James FDirector, CFO, Treasurer, Secretary | VICRVICOR CORP Option exercise · 10b5-1 plan | M | $100K 1,000 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 0 | D'Amico AndrewDirector | VICRVICOR CORP Option exercise · 10b5-1 plan | M | — 331 sh | Jun 29, 2026 traded Jun 26, 2026 |
| 50 | Calamos Aksia Hedged Strategies Fund (Offshore), Ltd.10% Owner | NACalamos Aksia Hedged Strategies Fund Open-market purchase | BUY | $405K 39.0K sh | Jun 26, 2026 traded Apr 27, 2026 |
| 49 | Swets Larry G JrDirector |  GLNDGreenland Energy CoOpen-market purchase | BUY | $30K 25.0K sh | Jun 26, 2026 traded May 12, 2026 |
| 48 | Ho EmilyChief Accounting Officer | SNOWSnowflake Inc. Open-market sale | SELL | $432K 1,860 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 45 | Employees' Retirement System of the State of Hawaii10% Owner | NALafayette Square USA, Inc. Open-market purchase | BUY | $20.00M 1.37M sh | Jun 26, 2026 traded Jun 26, 2026 |
| 42 | Gloria MelanieChief Operating Officer |  IMVTImmunovant, Inc.Open-market sale | SELL | $563K 14.7K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 42 | Van Tuyl ChristopherChief Legal Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $572K 15.0K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 42 | Stout Jay SChief Technology Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $1.27M 33.3K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 39 | McCurry Jennifer LynnChief Accounting Officer |  LZBLA-Z-BOY INCOpen-market sale | SELL | $153K 3,715 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 38 | Girao TiagoChief Financial Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $385K 10.0K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 36 | Marchington AndrewChief Financial Officer |  GRUSFGrown Rogue International Inc.Open-market sale | SELL | $602 1,400 sh | Jun 26, 2026 traded Apr 22, 2026 |
| 35 | Stout Jay SChief Technology Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $262K 6,723 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 35 | Smolyansky LudmilaMember of 10% owner group |  LWAYLifeway Foods, Inc.Open-market sale | SELL | $1.35M 45.6K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 35 | Van Tuyl ChristopherChief Legal Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $111K 2,842 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 35 | Smolyansky LudmilaMember of 10% owner group | LWAYLifeway Foods, Inc. Open-market sale | SELL | $1.20M 40.0K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 35 | Smolyansky Edward10% Owner | LWAYLifeway Foods, Inc. Open-market sale | SELL | $1.09M 36.7K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 35 | Gloria MelanieChief Operating Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $116K 2,966 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 34 | Stephenson Brian CChief Financial Officer |  FTHFaeth Therapeutics, Inc.Open-market purchase | BUY | $92K 3,400 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 34 | Stephenson Brian CChief Financial Officer | FTHFaeth Therapeutics, Inc. Open-market purchase | BUY | $105K 4,212 sh | Jun 26, 2026 traded Jun 26, 2026 |